These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19420116)

  • 1. Improvement of renal hemodynamics during hypertension-induced chronic renal disease: role of EGF receptor antagonism.
    Helle F; Jouzel C; Chadjichristos C; Placier S; Flamant M; Guerrot D; François H; Dussaule JC; Chatziantoniou C
    Am J Physiol Renal Physiol; 2009 Jul; 297(1):F191-9. PubMed ID: 19420116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Losartan increases NO release in afferent arterioles during regression of L-NAME-induced renal damage.
    Helle F; Iversen BM; Chatziantoniou C
    Am J Physiol Renal Physiol; 2010 May; 298(5):F1170-7. PubMed ID: 20219827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction.
    Banting JD; Friberg P; Adams MA
    J Hypertens; 1996 Aug; 14(8):975-81. PubMed ID: 8884552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide inhibition induces early activation of type I collagen gene in renal resistance vessels and glomeruli in transgenic mice. Role of endothelin.
    Chatziantoniou C; Boffa JJ; Ardaillou R; Dussaule JC
    J Clin Invest; 1998 Jun; 101(12):2780-9. PubMed ID: 9637712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of renal lesions following interruption of nitric oxide synthesis inhibition in transgenic mice.
    Placier S; Boffa JJ; Dussaule JC; Chatziantoniou C
    Nephrol Dial Transplant; 2006 Apr; 21(4):881-8. PubMed ID: 16384829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic alpha1-adrenergic blockade improves hypertension and renal injury in L-NAME and low-renin L-NAME-DOCA hypertensive rats.
    Wangensteen R; O'Valle F; Del Moral R; Vargas F; Osuna A
    Med Sci Monit; 2002 Sep; 8(9):BR378-84. PubMed ID: 12221376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of renal vascular and glomerular fibrosis by epidermal growth factor receptor inhibition.
    François H; Placier S; Flamant M; Tharaux PL; Chansel D; Dussaule JC; Chatziantoniou C
    FASEB J; 2004 May; 18(7):926-8. PubMed ID: 15033924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
    García-Estañ J; Ortiz MC; O'Valle F; Alcaraz A; Navarro EG; Vargas F; Evangelista S; Atucha NM
    Clin Sci (Lond); 2006 Feb; 110(2):227-33. PubMed ID: 16197366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure relationship to nitric oxide, lipid peroxidation, renal function, and renal blood flow in rats exposed to low lead levels.
    Dursun N; Arifoglu C; Süer C; Keskinol L
    Biol Trace Elem Res; 2005 May; 104(2):141-9. PubMed ID: 15894814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of orchiectomy on renal function in control and diabetic rats with chronic inhibition of nitric oxide.
    Anderson S; Chapman JG; Oyama TT; Komers R
    Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):19-23. PubMed ID: 19473197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition.
    Okazaki H; Minamino T; Tsukamoto O; Kim J; Okada K; Myoishi M; Wakeno M; Takashima S; Mochizuki N; Kitakaze M
    Hypertens Res; 2006 Apr; 29(4):277-84. PubMed ID: 16778335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide participates in the renal vasodilatory effect of candesartan in anesthetized rats.
    Demeilliers B; Mimran A; Jover B
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S208-12. PubMed ID: 9892165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT1-receptor blocker over thiazide alone on renoprotection in L-NAME/SHR.
    Zhou X; Matavelli LC; Ono H; Frohlich ED
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F871-9. PubMed ID: 15900021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic (-)-epicatechin improves vascular oxidative and inflammatory status but not hypertension in chronic nitric oxide-deficient rats.
    Gómez-Guzmán M; Jiménez R; Sánchez M; Romero M; O'Valle F; Lopez-Sepulveda R; Quintela AM; Galindo P; Zarzuelo MJ; Bailón E; Delpón E; Perez-Vizcaino F; Duarte J
    Br J Nutr; 2011 Nov; 106(9):1337-48. PubMed ID: 21910946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of L-NAME-induced hypertension: the role of nitric oxide and endothelium-derived constricting factor.
    Paulis L; Zicha J; Kunes J; Hojna S; Behuliak M; Celec P; Kojsova S; Pechanova O; Simko F
    Hypertens Res; 2008 Apr; 31(4):793-803. PubMed ID: 18633192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central and peripheral mechanisms involved in hypertension induced by chronic inhibition of nitric oxide synthase in rats.
    Liu Y; Tsuchihashi T; Kagiyama S; Matsumura K; Abe I; Fujishima M
    J Hypertens; 1998 Aug; 16(8):1165-73. PubMed ID: 9794721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous nitric oxide and epoxyeicosatrienoic acids modulate angiotensin II-induced constriction in the rabbit afferent arteriole.
    Kohagura K; Endo Y; Ito O; Arima S; Omata K; Ito S
    Acta Physiol Scand; 2000 Jan; 168(1):107-12. PubMed ID: 10691787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental activity of the renin-angiotensin system during the "critical period" modulates later L-NAME-induced hypertension and renal injury.
    Ishiguro K; Sasamura H; Sakamaki Y; Itoh H; Saruta T
    Hypertens Res; 2007 Jan; 30(1):63-75. PubMed ID: 17460373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal 20-HETE inhibition attenuates changes in renal hemodynamics induced by L-NAME treatment in pregnant rats.
    Huang H; Zhou Y; Raju VT; Du J; Chang HH; Wang CY; Brands MW; Falck JR; Wang MH
    Am J Physiol Renal Physiol; 2005 Nov; 289(5):F1116-22. PubMed ID: 15998843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.